155 related articles for article (PubMed ID: 7907393)
1. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
2. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
Solary E; Casasnovas RO; Campos L; Béné MC; Faure G; Maingon P; Falkenrodt A; Lenormand B; Genetet N
Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696
[TBL] [Abstract][Full Text] [Related]
3. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
Urbano-Ispizua A; Matutes E; Villamor N; Sierra J; Pujades A; Reverter JC; Feliu E; Cervantes F; Vives-Corrons JL; Montserrat E
Br J Haematol; 1992 Jun; 81(2):178-83. PubMed ID: 1322689
[TBL] [Abstract][Full Text] [Related]
4. Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study.
Kuerbitz SJ; Civin CI; Krischer JP; Ravindranath Y; Steuber CP; Weinstein HJ; Winick N; Ragab AH; Gresik MV; Crist WM
J Clin Oncol; 1992 Sep; 10(9):1419-29. PubMed ID: 1517785
[TBL] [Abstract][Full Text] [Related]
5. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.
Lee EJ; Yang J; Leavitt RD; Testa JR; Civin CI; Forrest A; Schiffer CA
Leukemia; 1992 Nov; 6(11):1203-9. PubMed ID: 1279324
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis.
Terstappen LW; Safford M; Könemann S; Loken MR; Zurlutter K; Büchner T; Hiddemann W; Wörmann B
Leukemia; 1992 Jan; 6(1):70-80. PubMed ID: 1540262
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia.
Schwarzinger I; Valent P; Köller U; Marosi C; Schneider B; Haas O; Knapp W; Lechner K; Bettelheim P
J Clin Oncol; 1990 Mar; 8(3):423-30. PubMed ID: 2307987
[TBL] [Abstract][Full Text] [Related]
8. Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy.
Campos L; Guyotat D; Archimbaud E; Devaux Y; Treille D; Larese A; Maupas J; Gentilhomme O; Ehrsam A; Fiere D
Br J Haematol; 1989 Jun; 72(2):161-6. PubMed ID: 2757962
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies in myeloid diseases: prognostic use in acute myeloid leukaemia.
Kristensen JS; Hokland P
Leuk Res; 1991; 15(8):693-700. PubMed ID: 1895750
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML.
Marosi C; Köller U; Koller-Weber E; Schwarzinger I; Schneider B; Jäger U; Vahls P; Nowotny H; Pirc-Danoewinata H; Steger G
Cancer Genet Cytogenet; 1992 Jul; 61(1):14-25. PubMed ID: 1638477
[TBL] [Abstract][Full Text] [Related]
11. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children.
Hurwitz CA; Raimondi SC; Head D; Krance R; Mirro J; Kalwinsky DK; Ayers GD; Behm FG
Blood; 1992 Dec; 80(12):3182-8. PubMed ID: 1467524
[TBL] [Abstract][Full Text] [Related]
12. CD7 positive acute myeloid leukaemia: a subtype associated with cell immaturity.
Lo Coco F; De Rossi G; Pasqualetti D; Lopez M; Diverio D; Latagliata R; Fenu S; Mandelli F
Br J Haematol; 1989 Dec; 73(4):480-5. PubMed ID: 2482063
[TBL] [Abstract][Full Text] [Related]
13. Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemia.
Dubosc-Marchenay N; Lacombe F; Dumain P; Marit G; Montastruc M; Belloc F; Reiffers J
Hematol Oncol; 1992; 10(5):235-49. PubMed ID: 1493908
[TBL] [Abstract][Full Text] [Related]
14. Surface marker expression in acute myeloid leukaemia at first relapse.
Thomas X; Campos L; Archimbaud E; Shi ZH; Treille-Ritouet D; Anglaret B; Fiere D
Br J Haematol; 1992 May; 81(1):40-4. PubMed ID: 1381608
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic significance of myelomonocytic cell surface antigens in acute myeloid leukaemia.
Merle-Beral H; Nguyen Cong Duc L; Leblond V; Boucheix C; Michel A; Chastang C; Debre P
Br J Haematol; 1989 Nov; 73(3):323-30. PubMed ID: 2605121
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic, genotypic, cytochemical, and ultrastructural characterization of acute undifferentiated leukemia.
Campana D; Hansen-Hagge TE; Matutes E; Coustan-Smith E; Yokota S; Shetty V; Bartram CR; Janossy G
Leukemia; 1990 Sep; 4(9):620-4. PubMed ID: 2395382
[TBL] [Abstract][Full Text] [Related]
17. Expression of a novel surface antigen MKW in childhood acute leukemia has prognostic significance.
Koehler M; Schell MJ; Behm FG; Raimondi SC; Woodruff LS; Mirro J
Leukemia; 1991 Jan; 5(1):41-8. PubMed ID: 1999957
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of lymphocyte surface markers in acute myeloid leukemia.
Ball ED; Davis RB; Griffin JD; Mayer RJ; Davey FR; Arthur DC; Wurster-Hill D; Noll W; Elghetany MT; Allen SL
Blood; 1991 May; 77(10):2242-50. PubMed ID: 1709379
[TBL] [Abstract][Full Text] [Related]
19. Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlations.
Paietta E; Van Ness B; Bennett J; Racevskis J; Gucalp R; Cassileth P; Wiernik PH
Br J Haematol; 1992 Oct; 82(2):324-31. PubMed ID: 1419814
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
Seshi B; Kashyap A; Bennett JM
Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
